Because scope 3 covers the entire value chain, pharma scientists should integrate sustainability into R&D, manufacturing, and ...

End-to-end CDMO services simplify drug development for small biopharma companies, reducing complexity, time, and costs while ...

Kimberly‑Clark said on Nov. 3, 2025 that it is planning to acquire Kenvue, the former Johnson & Johnson unit and maker of ...

As a part of its CPHI Frankfurt 2025 coverage, Pharmaceutical Technology ® interviewed Sriman Banerjee, PhD, executive ...

As Thermo Fisher’s Jennifer Cannon explains in this first part of a two-part interview, the collaboration is intended to help ...

In this PharmTech video feature, we highlight the week’s industry news in an easy-to-consume, fun format. New roundups will ...

CPHI Pharma Awards 2025 recognized innovations in bio/pharmaceutical development, emphasizing sustainability, drug delivery, ...

In the first part of this interview, Romanski tells PharmTech Group that while the field of oral dosage forms has not grown ...

The Critical Medicines Act (CMA) addresses supply chain vulnerabilities by redefining procurement criteria, emphasizing quality, security, and environmental standards. European manufacturers gain ...

When it comes to sustainability, Reed points to plant-based excipients, eco-efficient manufacturing, and bio-based circular ...

AI and accelerated computing are transforming the bio/pharmaceutical sector by addressing organizational, technological, and ...

Maggie Saykali, Cefic, explains that Western pharma vulnerability stems from market loss to Asia, caused largely by ...